Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(-)-2-Amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]pteridine-4(1H)-one, also known as L-erythro-pterin, is a naturally occurring pteridine derivative that serves as a crucial precursor in the synthesis of the cofactor tetrahydrobiopterin (BH4). (-)-2-Amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]pteridine-4(1H)-one plays a significant role in the production of neurotransmitters like dopamine and serotonin, as well as in the generation of nitric oxide. L-erythro-pterin also contributes to the regulation of the immune system and has potential therapeutic applications in treating diseases such as phenylketonuria, where BH4 deficiency results in the accumulation of toxic phenylalanine levels in the body. It represents a promising target for further research and development in medicine and biochemistry.

2277-43-2

Post Buying Request

2277-43-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2277-43-2 Usage

Uses

Used in Pharmaceutical Industry:
L-erythro-pterin is utilized as a therapeutic agent for the treatment of phenylketonuria, a genetic disorder characterized by BH4 deficiency. This deficiency leads to the accumulation of toxic levels of phenylalanine in the body, causing severe health issues. By addressing the BH4 deficiency, L-erythro-pterin helps mitigate the symptoms and complications associated with phenylketonuria.
Used in Neurotransmitter Production:
L-erythro-pterin plays a vital role as a precursor in the synthesis of tetrahydrobiopterin (BH4), which is an essential cofactor for the production of neurotransmitters such as dopamine and serotonin. These neurotransmitters are crucial for various physiological processes, including mood regulation, cognitive function, and motor control. By supporting neurotransmitter production, L-erythro-pterin contributes to maintaining proper brain function and overall mental health.
Used in Nitric Oxide Production:
L-erythro-pterin is involved in the generation of nitric oxide, a molecule with diverse functions in the body, including vasodilation, immune response regulation, and neurotransmission. By participating in nitric oxide production, L-erythro-pterin supports various physiological processes and contributes to overall health and well-being.
Used in Immune System Regulation:
L-erythro-pterin contributes to the regulation of the immune system, which is essential for defending the body against infections and maintaining overall health. By playing a role in immune system regulation, L-erythro-pterin helps ensure the proper functioning of the body's defense mechanisms.

Check Digit Verification of cas no

The CAS Registry Mumber 2277-43-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,2,7 and 7 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 2277-43:
(6*2)+(5*2)+(4*7)+(3*7)+(2*4)+(1*3)=82
82 % 10 = 2
So 2277-43-2 is a valid CAS Registry Number.

2277-43-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-amino-6-[(1R,2S)-1,2,3-trihydroxypropyl]-1H-pteridin-4-one

1.2 Other means of identification

Product number -
Other names Neopterin,L-erythro

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2277-43-2 SDS

2277-43-2Relevant articles and documents

Pteridines: Synthesis and characteristics of 5,6-dihydro-6-(1,2,3-trihydroxypropyl)pteridines: Covalent intramolecular adducts

Soyka,Pfleiderer,Prewo

, p. 808 - 826 (2007/10/02)

Various 5,6-diaminopyrimidines (1, 15, 24, 33) were condensed with the phenylhydrazones of L-(2) and D-arabinose (3) in acidic medium under N2 to give formal 5,6-dihydro-6-(1,2,3-trihydroxypropyl)pteridines (see, e.g., 4 and 5), the latter turned out to exist preferentially as intramolecular adducts, the hexahydropyrano-[3,2-g]pteridines 6, 7, 16, 17, 25, 26, and 34, formed subsequently by addition of the terminal OH group of the side-chain to the C(7)=N(8) bond of the pteridine moiety. Spectroscopically, the isomeric hexahydrofuro [3,2-g]pteridines 10, 11, 18, 19, and 35 were also detected as minor components in the equilibrium mixtures. In the 4-amino-2-(methylthio)pteridine series, crystallization of 6 and 7 led to the stereochemically pure (3S,4R,4aR,10aS)-6-amino-3,4,4a,5,10,10a-hexahydro-8-(methylthio -2H-pyrano[3,2-g]pteridine-3,4-diol (8) and its corresponding enantiomer 9, respectively. Structure 8 was proven by X-ray analysis. Acylation of the hexahydropyrano[3,2-g]pteridines yielded the more stable tri-, tetra-, and pentaacetyl derivatives 12-14, 20-23, 27-32, and 37-39 which were characterized and of which the absolute and relative configurations were determined (1H- and 13C-NMR and UV spectra, chiroptical measurements, elemental analyses).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2277-43-2